表紙:癌免疫治療薬の世界市場の分析・予測
市場調査レポート
商品コード
760795

癌免疫治療薬の世界市場の分析・予測

Global Immuno-Oncology Market Size, Status and Forecast 2020-2026

出版日: | 発行: QYResearch | ページ情報: 英文 92 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.68円
癌免疫治療薬の世界市場の分析・予測
出版日: 2020年03月09日
発行: QYResearch
ページ情報: 英文 92 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の癌免疫治療薬の市場を調査し、市場の定義と概要、タイプ・用途・地域/主要国別の動向と市場規模の推移と予測、市場成長への各種影響因子の分析、競合環境と市場シェア、主要製造業者のプロファイルなどをまとめています。

第1章 レポート概要

  • 調査範囲
  • 調査対象製造業者
  • 市場分析:タイプ別
    • 成長率
    • 免疫チェックポイント阻害剤
    • モノクローナル抗体
    • サイトカイン免疫療法
    • 癌ワクチン
    • CAR-T細胞療法
  • 市場分析:用途別
    • 市場シェア
    • 病院
    • 薬局
    • オンライン薬局
  • 調査対象
  • 調査対象年

第2章 世界の成長動向

  • 市場規模
  • 市場規模・市場シェア:地域別
  • 産業動向

第3章 主要企業・市場シェア

  • 収益・収益のシェア:企業別
  • 主要企業の本部・販売エリア
  • 主要企業の製品・ソリューション・サービス
  • 市場参入日
  • M&A・拡張計画

第4章 市場規模の推移:タイプ・用途別

第5章 米国市場の分析

  • 市場規模の推移
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第6章 欧州市場の分析

  • 市場規模の推移
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第7章 中国市場の分析

  • 市場規模の推移
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第8章 日本市場の分析

  • 市場規模の推移
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第9章 東南アジア市場の分析

  • 市場規模の推移
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第10章 インド市場の分析

  • 市場規模の推移
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第11章 中南米市場の分析

  • 市場規模の推移
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第12章 企業プロファイル

  • Amgen, Inc
  • AstraZeneca, Plc
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Eli Lilly and Company
  • Merck & Co.
  • Hoffmann-La Roche AG
  • Johnson & Johnson
  • Novartis International AG
  • AbbVie
  • Pfizer Inc.
  • Sanofi S.A.
  • EMD Serono
  • Gilead Sciences Inc.
  • Prometheus Therapeutics & Diagnostics
  • Aduro BioTech
  • Galena Biopharma
  • Bavarian Nordic
  • Celldex Therapeutics
  • ImmunoCellular Therapeutics
  • Incyte

第13章 市場予測

  • 市場予測:地域別
  • 市場予測:製品タイプ別
  • 市場予測:用途別

第14章 アナリストの見解・総論

第15章 付録

図表
  • Table 1. Immuno-Oncology Key Players Covered in 2019 1
  • Table 2. Global Immuno-Oncology Market Size Growth Rate by Type (2020-2026) (Million US$) 2
  • Table 3. Global Immuno-Oncology Market Size Growth by Application (2020-2026) (Million US$) 4
  • Table 4. Global Immuno-Oncology Market Size by Regions 2020-2026 (Million US$) 9
  • Table 5. Global Immuno-Oncology Market Size by Regions (2015-2020) (Million US$) 10
  • Table 6. Global Immuno-Oncology Market Share by Regions (2015-2020) 10
  • Table 7. Market Top Trends 12
  • Table 8. Key Drivers: Impact Analysis (2020-2026) 12
  • Table 9. Key Challenges 13
  • Table 10. Global Immuno-Oncology Revenue by Players (2019-2020) (Million US$) 14
  • Table 11. Global Immuno-Oncology Market Share by Players (2019-2020) 14
  • Table 12. Global Immuno-Oncology Players Market Concentration Ratio (CR5 and HHI) 16
  • Table 13. Key Players Headquarters and Established Date 16
  • Table 14. Key Players Immuno-Oncology Product/Solution/Service 17
  • Table 15. Mergers & Acquisitions, Expansion Plans 17
  • Table 16. Global Immuno-Oncology Market Size by Type (2015-2020) (Million US$) 20
  • Table 17. Global Immuno-Oncology Market Size Share by Type (2015-2020) 20
  • Table 18. Global Immuno-Oncology Market Size by Application (2015-2020) (Million US$) 22
  • Table 19. Global Immuno-Oncology Market Size Share by Application (2015-2020) 22
  • Table 20. United States Key Players Immuno-Oncology Revenue (2019-2020) (Million US$) 23
  • Table 21. United States Key Players Immuno-Oncology Market Share (2019-2020) 24
  • Table 22. United States Immuno-Oncology Market Size by Type (2015-2020) (Million US$) 24
  • Table 23. United States Immuno-Oncology Market Share by Type (2015-2020) 24
  • Table 24. United States Immuno-Oncology Market Size by Application (2015-2020) (Million US$) 25
  • Table 25. United States Immuno-Oncology Market Share by Application (2015-2020) 25
  • Table 26. Europe Key Players Immuno-Oncology Revenue (2019-2020) (Million US$) 26
  • Table 27. Europe Key Players Immuno-Oncology Market Share (2019-2020) 27
  • Table 28. Europe Immuno-Oncology Market Size by Type (2015-2020) (Million US$) 27
  • Table 29. Europe Immuno-Oncology Market Share by Type (2015-2020) 27
  • Table 30. Europe Immuno-Oncology Market Size by Application (2015-2020) (Million US$) 28
  • Table 31. Europe Immuno-Oncology Market Share by Application (2015-2020) 28
  • Table 32. Japan Key Players Immuno-Oncology Revenue (2019-2020) (Million US$) 29
  • Table 33. Japan Key Players Immuno-Oncology Market Share (2019-2020) 30
  • Table 34. Japan Immuno-Oncology Market Size by Type (2015-2020) (Million US$) 30
  • Table 35. Japan Immuno-Oncology Market Share by Type (2015-2020) 30
  • Table 36. Japan Immuno-Oncology Market Size by Application (2015-2020) (Million US$) 31
  • Table 37. Japan Immuno-Oncology Market Share by Application (2015-2020) 31
  • Table 38. China Key Players Immuno-Oncology Revenue (2019-2020) (Million US$) 32
  • Table 39. China Key Players Immuno-Oncology Market Share (2019-2020) 33
  • Table 40. China Immuno-Oncology Market Size by Type (2015-2020) (Million US$) 33
  • Table 41. China Immuno-Oncology Market Share by Type (2015-2020) 33
  • Table 42. China Immuno-Oncology Market Size by Application (2015-2020) (Million US$) 34
  • Table 43. China Immuno-Oncology Market Share by Application (2015-2020) 34
  • Table 44. Southeast Asia Key Players Immuno-Oncology Revenue (2019-2020) (Million US$) 35
  • Table 45. Southeast Asia Key Players Immuno-Oncology Market Share (2019-2020) 36
  • Table 46. Southeast Asia Immuno-Oncology Market Size by Type (2015-2020) (Million US$) 36
  • Table 47. Southeast Asia Immuno-Oncology Market Share by Type (2015-2020) 36
  • Table 48. Southeast Asia Immuno-Oncology Market Size by Application (2015-2020) (Million US$) 37
  • Table 49. Southeast Asia Immuno-Oncology Market Share by Application (2015-2020) 37
  • Table 50. India Key Players Immuno-Oncology Revenue (2019-2020) (Million US$) 38
  • Table 51. India Key Players Immuno-Oncology Market Share (2019-2020) 39
  • Table 52. India Immuno-Oncology Market Size by Type (2015-2020) (Million US$) 39
  • Table 53. India Immuno-Oncology Market Share by Type (2015-2020) 39
  • Table 54. India Immuno-Oncology Market Size by Application (2015-2020) (Million US$) 40
  • Table 55. India Immuno-Oncology Market Share by Application (2015-2020) 40
  • Table 56. Central & South America Key Players Immuno-Oncology Revenue (2019-2020) (Million US$) 41
  • Table 57. Central & South America Key Players Immuno-Oncology Market Share (2019-2020) 42
  • Table 58. Central & South America Immuno-Oncology Market Size by Type (2015-2020) (Million US$) 42
  • Table 59. Central & South America Immuno-Oncology Market Share by Type (2015-2020) 42
  • Table 60. Central & South America Immuno-Oncology Market Size by Application (2015-2020) (Million US$) 43
  • Table 61. Central & South America Immuno-Oncology Market Share by Application (2015-2020) 43
  • Table 62. Bristol-Myers Squibb Corporation Information 44
  • Table 63. Bristol-Myers Squibb Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 45
  • Table 64. Merck & Co., Inc. Corporation Information 46
  • Table 65. Merck & Co., Inc. Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 47
  • Table 66. Roche AG Corporation Information 48
  • Table 67. Roche AG Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 49
  • Table 68. AstraZeneca, Plc Corporation Information 50
  • Table 69. AstraZeneca, Plc Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 51
  • Table 70. Sanofi S.A. Corporation Information 51
  • Table 71. Sanofi S.A. Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 53
  • Table 72. Dendreon Pharmaceuticals Corporation Information 53
  • Table 73. Dendreon Pharmaceuticals Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 55
  • Table 74. Novartis Corporation Information 56
  • Table 75. Novartis Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 57
  • Table 76. Gilead Sciences Inc. Corporation Information 58
  • Table 77. Gilead Sciences Inc. Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 60
  • Table 78. Merck KGaA Corporation Information 60
  • Table 79. Merck KGaA Immuno-Oncology Revenue (US$ Million) and Gross Margin (2019-2020) 62
  • Table 80. Global Immuno-Oncology Market Size by Regions (Million US$) 2020-2026 63
  • Table 81. Global Immuno-Oncology Market Size by Product (2020-2026) (Million USD) 67
  • Table 82. Global Immuno-Oncology Market Size by Application (2020-2026) (Million USD) 69
  • Table 83. Research Programs/Design for This Report 72
  • Table 84. Key Data Information from Secondary Sources 76
  • Table 85. Key Data Information from Primary Sources 77
  • Figure 1. Global Immuno-Oncology Market Share by Type in 2019 3
  • Figure 2. Global Immuno-Oncology Market Share by Application in 2019 5
  • Figure 3. Hospitals Case Studies 6
  • Figure 4. Drugstores Case Studies 6
  • Figure 5. Immuno-Oncology Report Years Considered 7
  • Figure 6. Global Immuno-Oncology Market Size and Growth Rate 2015-2026 (Million US$) 8
  • Figure 7. Global Immuno-Oncology Market Size by Regions 2020 & 2026 (Million US$) 9
  • Figure 8. Global Immuno-Oncology Market Share by Regions (2015-2020) 11
  • Figure 9. Global Immuno-Oncology Market Share by Regions 2019 11
  • Figure 10. Porter's Five Forces Analysis 13
  • Figure 11. Global Immuno-Oncology Market Share by Players in 2019 15
  • Figure 12. Global Immuno-Oncology Market Size Share by Type (2015-2020) 21
  • Figure 13. Global Immuno-Oncology Revenue Market Share by Type in 2019 21
  • Figure 14. Global Immuno-Oncology Revenue Market Share by Application in 2019 22
  • Figure 15. United States Immuno-Oncology Market Size 2015-2020 (Million US$) 23
  • Figure 16. Europe Immuno-Oncology Market Size 2015-2020 (Million US$) 26
  • Figure 17. Japan Immuno-Oncology Market Size 2015-2020 (Million US$) 29
  • Figure 18. China Immuno-Oncology Market Size 2015-2020 (Million US$) 32
  • Figure 19. Southeast Asia Immuno-Oncology Market Size 2015-2020 (Million US$) 35
  • Figure 20. India Immuno-Oncology Market Size 2015-2020 (Million US$) 38
  • Figure 21. Central & South America Immuno-Oncology Market Size 2015-2020 (Million US$) 41
  • Figure 22. Immuno-Oncology Product Information of Bristol-Myers Squibb 45
  • Figure 23. Merck & Co., Inc. Immuno-Oncology Product Information 47
  • Figure 24. Roche AG Immuno-Oncology Product Information 49
  • Figure 25. AstraZeneca, Plc Immuno-Oncology Product Information 51
  • Figure 26. Sanofi S.A. Immuno-Oncology Product Information 53
  • Figure 27. Dendreon Pharmaceuticals Immuno-Oncology Product Information 55
  • Figure 28. Novartis Immuno-Oncology Product Information 57
  • Figure 29. Gilead Sciences Inc. Immuno-Oncology Product Information 59
  • Figure 30. Merck KGaA Immuno-Oncology Product Information 61
  • Figure 31. Global Immuno-Oncology Market Size Share by Regions (2020-2026) 63
  • Figure 32. Global Immuno-Oncology Market Size Share by Regions in 2025 64
  • Figure 33. United States Immuno-Oncology Market Size Forecast (2020-2026) (Million USD) 64
  • Figure 34. Europe Immuno-Oncology Market Size Forecast (2020-2026) (Million USD) 65
  • Figure 35. Japan Immuno-Oncology Market Size Forecast (2020-2026) (Million USD) 65
  • Figure 36. China Immuno-Oncology Market Size Forecast (2020-2026) (Million USD) 66
  • Figure 37. Southeast Asia Immuno-Oncology Market Size Forecast (2020-2026) (Million USD) 66
  • Figure 38. India Immuno-Oncology Market Size Forecast (2020-2026) (Million USD) 67
  • Figure 39. Global Immuno-Oncology Market Size by Product (2020-2026) 68
  • Figure 40. Global Immuno-Oncology Market Size by Product in 2025 68
  • Figure 41. Global Immuno-Oncology Market Size by Application (2020-2026) 69
  • Figure 42. Global Immuno-Oncology Market Size by Application in 2025 70
  • Figure 43. Bottom-up and Top-down Approaches for This Report 74
  • Figure 44. Data Triangulation 75
  • Figure 45. Key Executives Interviewed 77
目次

In 2019, the global Immuno-Oncology market size was 32452 million US$ and it is expected to reach 87432 million US$ by the end of 2026, with a CAGR of 14.92% during 2020-2026.

This report focuses on the global Immuno-Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immuno-Oncology development in United States, Europe, Japan, China, Southeast Asia, India, Central & South America.

By Company

Bristol-Myers Squibb

Merck & Co

Roche AG

AstraZeneca, Plc

Sanofi S.A.

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc.

Merck KGaA

By Product Type

Immune Checkpoint Inhibitors

Cytokine-Based Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy

Other

By Application

Hospitals

Drugstores

Others

United States

Europe

China

Japan

India

Southeast Asia

Central & South America

1 REPORT OVERVIEW 1

  • 1.1 STUDY SCOPE 1
  • 1.2 KEY MARKET SEGMENTS 1
  • 1.3 PLAYERS COVERED 1
  • 1.4 MARKET ANALYSIS BY TYPE 2
    • 1.4.1 Global Immuno-Oncology Market Size Growth Rate by Type (2020-2026) 2
    • 1.4.2 Immune Checkpoint Inhibitors 3
    • 1.4.3 Cytokine-Based Immunotherapy 3
    • 1.4.4 Cancer Vaccines 3
    • 1.4.5 CAR-T Cell Therapy 4
  • 1.5 MARKET BY APPLICATION 4
    • 1.5.1 Global Immuno-Oncology Market Share by Application (2020-2026) 4
    • 1.5.2 Hospitals 5
    • 1.5.3 Drugstores 6
  • 1.6 STUDY OBJECTIVES 7
  • 1.7 YEARS CONSIDERED 7

2 GLOBAL GROWTH TRENDS 8

  • 2.1 GLOBAL IMMUNO-ONCOLOGY MARKET SIZE 8
  • 2.2 IMMUNO-ONCOLOGY GROWTH TRENDS BY REGIONS 9
    • 2.2.1 Immuno-Oncology Market Size by Regions (2020-2026) 9
    • 2.2.2 Immuno-Oncology Market Share by Regions (2015-2020) 10
  • 2.3 INDUSTRY TRENDS 12
    • 2.3.1 Market Top Trends 12
    • 2.3.2 Market Drivers 12
    • 2.3.3 Market Challenges 12
    • 2.3.4 Porter's Five Forces Analysis 13

3 MARKET SHARE BY KEY PLAYERS 14

  • 3.1 IMMUNO-ONCOLOGY MARKET SIZE BY PLAYERS 14
    • 3.1.1 Global Immuno-Oncology Revenue by Players (2019-2020) 14
    • 3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2019-2020) 14
    • 3.1.3 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI) 16
  • 3.2 IMMUNO-ONCOLOGY KEY PLAYERS HEADQUARTERS AND ESTABLISHED DATE 16
  • 3.3 KEY PLAYERS IMMUNO-ONCOLOGY PRODUCT/SOLUTION/SERVICE 17
  • 3.4 MERGERS & ACQUISITIONS, EXPANSION PLANS 17

4 BREAKDOWN DATA BY TYPE AND APPLICATION 20

  • 4.1 GLOBAL IMMUNO-ONCOLOGY MARKET SIZE BY TYPE (2015-2020) 20
  • 4.2 GLOBAL IMMUNO-ONCOLOGY MARKET SIZE BY APPLICATION (2015-2020) 22

5 UNITED STATES 23

  • 5.1 UNITED STATES IMMUNO-ONCOLOGY MARKET (2015-2020) 23
  • 5.2 IMMUNO-ONCOLOGY KEY PLAYERS IN UNITED STATES 23
  • 5.3 UNITED STATES IMMUNO-ONCOLOGY MARKET SIZE BY TYPE 24
  • 5.4 UNITED STATES IMMUNO-ONCOLOGY MARKET SIZE BY APPLICATION 25

6 EUROPE 26

  • 6.1 EUROPE IMMUNO-ONCOLOGY MARKET (2015-2020) 26
  • 6.2 IMMUNO-ONCOLOGY KEY PLAYERS IN EUROPE 26
  • 6.3 EUROPE IMMUNO-ONCOLOGY MARKET SIZE BY TYPE 27
  • 6.4 EUROPE IMMUNO-ONCOLOGY MARKET SIZE BY APPLICATION 28

7 JAPAN 29

  • 7.1 JAPAN IMMUNO-ONCOLOGY MARKET (2015-2020) 29
  • 7.2 IMMUNO-ONCOLOGY KEY PLAYERS IN JAPAN 29
  • 7.3 JAPAN IMMUNO-ONCOLOGY MARKET SIZE BY TYPE 30
  • 7.4 JAPAN IMMUNO-ONCOLOGY MARKET SIZE BY APPLICATION 31

8 CHINA 32

  • 8.1 CHINA IMMUNO-ONCOLOGY MARKET (2015-2020) 32
  • 8.2 IMMUNO-ONCOLOGY KEY PLAYERS IN CHINA 32
  • 8.3 CHINA IMMUNO-ONCOLOGY MARKET SIZE BY TYPE 33
  • 8.4 CHINA IMMUNO-ONCOLOGY MARKET SIZE BY APPLICATION 34

9 SOUTHEAST ASIA 35

  • 9.1 SOUTHEAST ASIA IMMUNO-ONCOLOGY MARKET (2015-2020) 35
  • 9.2 IMMUNO-ONCOLOGY KEY PLAYERS IN SOUTHEAST ASIA 35
  • 9.3 SOUTHEAST ASIA IMMUNO-ONCOLOGY MARKET SIZE BY TYPE 36
  • 9.4 SOUTHEAST ASIA IMMUNO-ONCOLOGY MARKET SIZE BY APPLICATION 37

10 INDIA 38

  • 10.1 INDIA IMMUNO-ONCOLOGY MARKET (2015-2020) 38
  • 10.2 IMMUNO-ONCOLOGY KEY PLAYERS IN INDIA 38
  • 10.3 INDIA IMMUNO-ONCOLOGY MARKET SIZE BY TYPE 39
  • 10.4 INDIA IMMUNO-ONCOLOGY MARKET SIZE BY APPLICATION 40

11 CENTRAL & SOUTH AMERICA 41

  • 11.1 CENTRAL & SOUTH AMERICA IMMUNO-ONCOLOGY MARKET (2015-2020) 41
  • 11.2 IMMUNO-ONCOLOGY KEY PLAYERS IN CENTRAL & SOUTH AMERICA 41
  • 11.3 CENTRAL & SOUTH AMERICA IMMUNO-ONCOLOGY MARKET SIZE BY TYPE 42
  • 11.4 CENTRAL & SOUTH AMERICA IMMUNO-ONCOLOGY MARKET SIZE BY APPLICATION 43

12 COMPANY PROFILES AND KEY FIGURES IN IMMUNO-ONCOLOGY BUSINESS 44

  • 12.1 BRISTOL-MYERS SQUIBB 44
    • 12.1.1 Bristol-Myers Squibb Corporation Information 44
    • 12.1.2 Product Information 45
    • 12.1.3 Bristol-Myers Squibb Immuno-Oncology Revenue and Gross Margin (2019-2020) 45
  • 12.2 MERCK & CO., INC. 46
    • 12.2.1 Merck & Co., Inc. Corporation Information 46
    • 12.2.2 Merck & Co., Inc. Product Information 47
    • 12.2.3 Merck & Co., Inc. Immuno-Oncology Revenue and Gross Margin (2019-2020) 47
  • 12.3 ROCHE AG 48
    • 12.3.1 Roche AG Corporation Information 48
    • 12.3.2 Roche AG Product Information 49
    • 12.3.3 Roche AG Immuno-Oncology Revenue and Gross Margin (2019-2020) 49
  • 12.4 ASTRAZENECA, PLC 50
    • 12.4.1 AstraZeneca, Plc Corporation Information 50
    • 12.4.2 AstraZeneca, Plc Product Information 51
    • 12.4.3 AstraZeneca, Plc Immuno-Oncology Revenue and Gross Margin (2019-2020) 51
  • 12.5 SANOFI S.A. 51
    • 12.5.1 Sanofi S.A. Corporation Information 51
    • 12.5.2 Sanofi S.A. Product Information 53
    • 12.5.3 Sanofi S.A. Immuno-Oncology Revenue and Gross Margin (2019-2020) 53
  • 12.6 DENDREON PHARMACEUTICALS 53
    • 12.6.1 Dendreon Pharmaceuticals Corporation Information 53
    • 12.6.2 Dendreon Pharmaceuticals Product Information 55
    • 12.6.3 Dendreon Pharmaceuticals Immuno-Oncology Revenue and Gross Margin (2019-2020) 55
  • 12.7 NOVARTIS 56
    • 12.7.1 Novartis Corporation Information 56
    • 12.7.2 Novartis Product Information 57
    • 12.7.3 Novartis Immuno-Oncology Revenue and Gross Margin (2019-2020) 57
  • 12.8 GILEAD SCIENCES INC. 58
    • 12.8.1 Gilead Sciences Inc. Corporation Information 58
    • 12.8.2 Gilead Sciences Inc. Product Information 59
    • 12.8.3 Gilead Sciences Inc. Immuno-Oncology Revenue and Gross Margin (2019-2020) 60
  • 12.9 MERCK KGAA 60
    • 12.9.1 Merck KGaA Corporation Information 60
    • 12.9.2 Merck KGaA Product Information 61
    • 12.9.3 Merck KGaA Immuno-Oncology Revenue and Gross Margin (2019-2020) 62

13 MARKET FORECAST 2020-2026 63

  • 13.1 MARKET SIZE FORECAST BY REGIONS 63
  • 13.2 UNITED STATES 64
  • 13.3 EUROPE 65
  • 13.4 JAPAN 65
  • 13.5 CHINA 66
  • 13.6 SOUTHEAST ASIA 66
  • 13.7 INDIA 67
  • 13.8 MARKET SIZE FORECAST BY PRODUCT (2020-2026) 67
  • 13.9 MARKET SIZE FORECAST BY APPLICATION (2020-2026) 69

14 ANALYST'S VIEWPOINTS/CONCLUSIONS 71

15 APPENDIX 72

  • 15.1 RESEARCH METHODOLOGY 72
    • 15.1.1 Methodology/Research Approach 72
    • 15.1.2 Data Source 75
  • 15.2 DISCLAIMER 78
  • 15.3 AUTHOR DETAILS 78